Results
2301
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2301 companies
CVS Group
Market Cap: UK£886.7m
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG
UK£12.60
7D
1.1%
1Y
12.7%
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.50
7D
-4.0%
1Y
-17.6%
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$57.81
7D
-2.1%
1Y
-8.4%
Pediatrix Medical Group
Market Cap: US$1.2b
Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
MD
US$13.72
7D
-9.6%
1Y
89.0%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$75.42
7D
-2.4%
1Y
-24.4%
Kestra Medical Technologies
Market Cap: US$1.2b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$22.86
7D
-1.0%
1Y
n/a
Neuren Pharmaceuticals
Market Cap: AU$1.8b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$14.13
7D
10.0%
1Y
-31.8%
Viridian Therapeutics
Market Cap: US$1.1b
Engages in discovering, developing, and commercializing treatments for serious and rare diseases.
VRDN
US$13.50
7D
-1.2%
1Y
12.7%
Natus Medical
Market Cap: US$1.1b
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.
NTUS
US$32.96
7D
0.8%
1Y
34.4%
Ocular Therapeutix
Market Cap: US$1.1b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.89
7D
8.1%
1Y
34.4%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$7.98
7D
-4.3%
1Y
54.7%
Establishment Labs Holdings
Market Cap: US$1.1b
A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
ESTA
US$35.89
7D
0.04%
1Y
-30.6%
Aveanna Healthcare Holdings
Market Cap: US$1.1b
A diversified home care platform company, provides pediatric and adult healthcare services in the United States.
AVAH
US$5.30
7D
-3.5%
1Y
103.8%
BioLife Solutions
Market Cap: US$1.1b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$22.35
7D
1.2%
1Y
3.5%
10x Genomics
Market Cap: US$1.1b
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
TXG
US$8.86
7D
6.5%
1Y
-59.9%
Spire Healthcare Group
Market Cap: UK£775.8m
Owns and operates private hospitals and clinics in the United Kingdom.
SPI
UK£1.93
7D
0%
1Y
-23.3%
OPKO Health
Market Cap: US$1.0b
A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
OPK
US$1.30
7D
0%
1Y
-5.1%
Oculis Holding
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$19.60
7D
6.8%
1Y
64.3%
Mineralys Therapeutics
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.
MLYS
US$15.84
7D
-4.9%
1Y
28.7%
MiMedx Group
Market Cap: US$999.9m
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$6.51
7D
-5.7%
1Y
-9.0%
Phibro Animal Health
Market Cap: US$991.5m
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
PAHC
US$24.50
7D
5.4%
1Y
35.0%
Integra LifeSciences Holdings
Market Cap: US$986.9m
Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
IART
US$12.68
7D
0.2%
1Y
-58.8%
SS Innovations International
Market Cap: US$983.5m
Operates as a commercial-stage surgical robotics company in India and internationally.
SSII
US$5.08
7D
-43.0%
1Y
21.2%
CareDx
Market Cap: US$981.6m
Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.
CDNA
US$17.56
7D
3.0%
1Y
30.5%
CureVac
Market Cap: US$979.4m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$4.44
7D
13.8%
1Y
17.2%
Pennant Group
Market Cap: US$977.2m
Provides healthcare services in the United States.
PNTG
US$27.86
7D
-2.7%
1Y
20.1%
Harrow
Market Cap: US$966.3m
An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
HROW
US$25.92
7D
-3.0%
1Y
45.4%
Intellia Therapeutics
Market Cap: US$965.9m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$9.66
7D
5.0%
1Y
-55.4%
NeoGenomics
Market Cap: US$965.2m
Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.
NEO
US$7.42
7D
0.3%
1Y
-46.3%
Craneware
Market Cap: UK£714.4m
Develops, licenses, and supports computer software for the healthcare industry in the United States.
CRW
UK£20.70
7D
-2.1%
1Y
-13.8%
Arcus Biosciences
Market Cap: US$956.1m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$9.13
7D
6.0%
1Y
-39.7%
Ardelyx
Market Cap: US$949.8m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.91
7D
-2.0%
1Y
-40.8%
Geron
Market Cap: US$949.0m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.45
7D
8.2%
1Y
-56.3%
Collegium Pharmaceutical
Market Cap: US$947.6m
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$28.91
7D
-1.9%
1Y
-12.9%
STAAR Surgical
Market Cap: US$936.7m
Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
STAA
US$18.08
7D
-2.0%
1Y
-55.0%
agilon health
Market Cap: US$923.1m
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.35
7D
0%
1Y
-59.2%